Galderma recognizes the importance of supporting residency programs that provide formal and structured on-label injection trainings involving our portfolio of aesthetic injectable products. Results of such activities may lead to greater understanding of the therapeutic areas that we treat, our products and their potential applications, as well as improved patient care.
We accept unsolicited requests for in-kind product grants from ACGME-accredited dermatology, plastic surgery, ophthalmology, or otolaryngology residency programs who are interested in conducting their own on-label injection trainings. Each program may submit 1 request per academic year. Please note that submissions/contracts do not automatically renew each academic year.
Residency program trainings should be conducted independently from Galderma; therefore, these grants are limited to the provision of in-kind product support only.
Please note, we will begin accepting requests for the next academic year starting August 1st.
Please note, we are not accepting requests at this time, please check back in 2025
Galderma is interested in Medical Education (ME) Activities that leads to a greater
understanding of the therapeutic areas that we treat, our products and their potential
applications, as well as improved patient care. Requests for ME Activity support must align
with the company's defined areas of strategic interest. Currently these include:
- Prescription
- Aesthetics
- Hyaluronic acid fillers
- Poly-L-lactic acid (PLLA)
- Neuromodulators
- Consumer Skincare
- Moisturizers
- Cleansers
- Acne Medications
For further information on Galderma's areas of interest, please visit www.nestleskinhealth.com/us.
PRODUCTS AVAILABLE FOR IN-KIND PRODUCT SUPPORT
Only the aesthetic injectable products (Dysport®, Restylane® family of products, and Sculptra®) are available for request. To view our current portfolio of products, please visit www.galderma.com/us/our-brands.
SUPPORT OF FELLOWS
Galderma does not provide medical grants to support fellow training. Please contact your local Galderma Sales Representative to request product samples for fellows.
SUPPORT THAT WILL NOT BE CONSIDERED
We will not consider requests in support of the following:
-
Non-ACGME-accredited residency programs, or programs outside those listed as being eligible
-
Requests for product to be shipped to a fellow, resident, the program coordinator, any physician's private practice, or a medical facility other than the requesting academic institution
-
Residency programs outside of the U.S.
Residency programs may submit 1 product request per academic year and each program may receive 1 product shipment per semester (fall, spring, and summer) for that school year. Submission deadlines for each semester are enforced. A formal notification will be sent to the requestor with the decision following review of the request (typically within 10 business days following request submission). Should additional information be needed to make a decision, a request for additional information will be issued by email.
SUBMISSION REQUIREMENTS
The following information is required for residency product requests:
-
Number of residents in program
-
Academic semesters product will be used
-
Shipping address of the program director
SUBMISSION DEADLINES
To ensure that we can review and process your request before the end of the semester, the following submission deadlines are enforced:
Semester
|
Deadline
|
Fall
|
September 30th
|
Spring
|
March 30th
|
Summer
|
June 30th
|
Requests for the new academic year are accepted beginning on August 1st of each year. Submissions/contracts are not automatically renewed. Each program is required to submit a new request each academic year. While requests may be submitted at any time during the school year, support will not be considered for any semesters in your request for which the submission deadline has passed.
AGREEMENT
If the request is approved, a contract will be sent through DocuSign® for execution between the residency program director and Galderma. Support is contingent upon a fully executed contract, compliance with the terms and conditions of the contract, as well as availability of time within the semester to conduct the product training.
PRODUCT SHIPPING & DELIVERY
Product is shipped directly to the program director at their academic institution only. Product will not be shipped to a resident, the program coordinator, any physician's private practice, or a medical facility other than the requesting academic institution.
The exact shipping and delivery dates will be determined by Galderma after execution of the Agreement. Deliveries are typically scheduled for Tuesday, Wednesday, or Thursday.
Please be aware that some product may arrive in temperature-sensitive shipments. All efforts should be made to ensure that delivery is intercepted in a timely manner and product is stored appropriately. Galderma will not provide replacement product if product is not handled appropriately once delivered to your organization resulting in the product becoming unusable.
LEFTOVER/REMAINING PRODUCT
Please note that some products' shelf-lives may not extend the duration of the semester. Upon receipt of the product shipment, expiration dates should be noted and a reasonable attempt to use all of the provided product should be made. Galderma will not replace products that expire prior to the end of a semester given that enough time was allowed for the residency program to reasonably use the product upon receipt. Once the product expires or is no longer viable, the program director should destroy the product at their own expense.
Who May Apply
Requests for in-kind product must come directly from the Residency Program Director.
- The Program Director must be a licensed medical doctor (MD) or a doctor of osteopathic
medicine (DO) from an ACGME-accredited dermatology, plastic surgery, otolaryngology, or
ophthalmology teaching program.
- The Program Director must have a valid and current state medical license number.
Galderma does not accept Grant Requests from or for individual physicians or groups of
physicians.
Submission Requirements
The following information is required to submit a request for in-kind product:
- Number of Residents in Program; and
- Quantity of In-Kind Product Requested From Galderma.
Letter of Agreement
Upon approval of a request, Galderma will enter into a Letter of Agreement (LOA) with the
Academic Institution as the Activity Provider. All Medical Education (ME) activities
supported by Galderma must abide by the terms of Galderma's LOA; no other LOAs will be
accepted. Galderma may not provide in-kind product support to the Academic Institution
until a Letter of Agreement (LOA) has been fully executed. Please note that, the LOA must
be executed with a reasonable amount of time left in the semester for the product training
to be conducted to use the product.
The LOA requires the Academic Institution to:
- Retain control over the design and conduct of the Activity;
- Conduct the Activity independently, without any influence from Galderma;
- Ensure that the Activity is unbiased, objective, and addresses all relevant treatment
options, rather than focusing on a single product;
- Provide meaningful disclosure to the audience (i.e., disclosure that is reasonably
calculated to reach the relevant audience in a manner that will alert them to potential
biases) at the beginning of the Activity regarding Galderma's financial support and
acknowledge Galderma as a source of funding for the Activity in any written materials;
and
- Make available a reasonable opportunity for discussion and a question-and-answer
session at the end of the Activity.
Product Shipping & Delivery
Product is shipped directly to the Program Director at their Academic Institution only.
Product will not be shipped to a resident, the Program Coordinator, any physician's private
practice, or a medical facility other than the requesting Academic Institution.
The exact shipping and delivery dates will be determined by Galderma after an internal
review and execution of a LOA between Galderma and the Residency Program Director on behalf
of the Academic Institution as the Activity Provider. Deliveries are typically scheduled
for Tuesday, Wednesday, or Thursday.
Please be aware that Dysport® has specific temperature requirements for shipping and
storing. All efforts should be made to ensure that delivery is intercepted in a timely
manner, as replacement product will not be provided if a delivery is missed by the Academic
Institution and the product becomes no longer viable. Care should be taken to ensure that
Dysport® is protected from light and that temperature control at 2°C, 8°C (36°F, 46°F) is
maintained during shipping and storing.
Leftover/Remaining Product
Please note that some products' shelf-lives may not extend the duration of the semester.
Upon receipt of the product(s), the Residency Program Director shall note the expiration
dates and make a reasonable attempt to use all of the products provided. Galderma will not
replace products that expire prior to the end of a semester given that enough time was
allowed for the residency program to reasonably use the product. Once the product expires
or is no longer viable, the Program Director may destroy the product at their own expense.
Updates
Activity Providers are required to notify Galderma of any of the following updates:
- Change of Scope; and
- Progress Reports, if applicable.
Change of Scope
Any ME Activity that undergoes significant changes requires a "Change of Scope"
notification to Galderma. These changes will be re-reviewed by the committee and could
result in a change in the support that Galderma has committed to that ME Activity. These
changes must be submitted in writing to usmedicalgrants@galderma.com.
Please submit the following information:
- Reference number of original ME Activity;
- Changes from the initial grant request;
- Rationale for changes; and
- Any updated documents (e.g., activity detail, agenda, brochure, budget, etc.).
Progress Reports
For ME Activities that include multiple components, or occur over a longer period of time,
progress reports and interim update notifications of any major progress (e.g., launch of
program, completion of program, etc.) should be provided to Galderma. Progress report
timing will be dependent on the length of the ME Activity and may be monthly, bi-monthly,
or quarterly.
Post-Activity Reconciliations
Upon completion of the ME Activity, the Activity Provider must submit the following
reconciliations:
- Outcomes Measurement Report;
- Budget Reconciliation; and
- Product Reconciliation.
If Galderma does not receive all reconciliations, the Activity Provider will not be allowed
to request additional support from Galderma.
Outcomes Measurement Report
The Outcomes Measurement Report should detail the following:
- Program Summary
- Type of Event/Activity
- Participation Demographics
- An overall summary that demonstrates the ME Activity met its stated learning
objectives
- Participant Evaluation Form Summary
- Summary of any pre-test and post-test results
- Post-activity Results Summary
Budget Reconciliation
The Activity Provider must be able to produce accurate documentation detailing the receipt
and expenditure of Galderma's monetary grant support. This budget reconciliation must
detail the following:
- Planned expenses as provided in the initial grant request application;
- Actual expenses spent during the course of the ME Activity, including how Galderma's
funds were allocated;
- Unused support from Galderma; and
- Sources of income for the Activity (multi-supported activities should list all sources
of income, not just the granted funds from Galderma).
If there are any unused grant funds after ME Activity completion, the Activity Provider
will be required to refund an amount proportional to the amount of funding Galderma
originally provided.
Product Reconciliation
The Activity Provider will certify in writing that all product was used during the ME
Activity, or that there is remaining unused or partially used product that needs to be
returned or destroyed. The Activity Provider will send a notification e-mail following the
ME Activity completion.
We are committed to maintaining integrity in all of our professional relationships. We operate under the highest ethical standards and in full compliance with all applicable laws, regulations, industry codes, and guidelines. Approval of in-kind support is never related to or conditioned upon past or future prescriptions or purchases of Galderma products. Furthermore, we do not offer, or provide funding to encourage or to reward the prescription, purchase, ordering, or recommending of Galderma products.
Our grant review and approval process is in full accordance with the recommendations and the guidance of the US Food and Drug Administration (FDA), the Accreditation Council for Continuing Medical Education (ACCME), the Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, the PhRMA Code on Interaction with Health Care Professionals, the AdvaMed Code of Ethics on Interactions with Health Care Providers, and National Physician Payment Transparency Program: Open Payments "Physician Payment Sunshine Act", as well as internal Galderma policies.
SUBMISSION CONFIDENTIALITY
By submitting your request for review, you agree that the information is not confidential, nor proprietary, and may be referred to a number of different persons at Galderma to determine the level of interest in supporting your request.
DISCLOSURE OF SUPPORT
Disclosure of in-kind support must be provided to the learners prior to the beginning of the educational activity, in one or more of the following: program brochures, syllabi, and other program materials, and at the time of the activity. This disclosure will not include the use of a trade name, product-group message or commercial interest's logo. The acknowledgment of commercial support may state the name of the company only.